2025-12-30 - Analysis Report
Okay, here's a comprehensive analysis of Exxon Mobil (XOM) based on the data provided, broken down into simple numbers and then followed by analysis.

**Simple Numbers & Data Summary:**

**1. Performance vs. S&P 500 (VOO):**

*   **XOM Cumulative Return:** 23.68%
*   **VOO Cumulative Return:** 103.21%
*   **Return Divergence (XOM - VOO):** -79.53%
*   **Relative Divergence (Within Historical Range):** 15.9%

**Company Overview:** Exxon Mobil Corp is an integrated oil and gas company that explores for and produces crude oil and natural gas.

**Alpha, Beta, and Financial Ratios:**

| Year       | CAGR     | MDD    | Alpha    | Beta   | Cap(B) |
|------------|----------|--------|----------|--------|--------|
| 2015-2017  | 9.0%     | 65.6%  | -19.0%   | 0.0    | 360.8  |
| 2016-2018  | -5.0%    | 71.1%  | -21.0%   | 0.1    | 294.2  |
| 2017-2019  | -6.0%    | 71.1%  | -28.0%   | -0.5   | 301.0  |
| 2018-2020  | -34.0%   | 78.8%  | -57.0%   | -0.4   | 177.8  |
| 2019-2021  | -3.0%    | 78.8%  | -49.0%   | -0.9   | 264.0  |
| 2020-2022  | 48.0%    | 81.8%  | 48.0%    | -0.1   | 475.8  |
| 2021-2023  | 39.0%    | 81.8%  | 37.0%    | 0.5    | 431.3  |
| 2022-2024  | 7.0%     | 81.8%  | -13.0%   | 0.8    | 464.1  |
| 2023-2025  | -14.0%   | 77.7%  | -82.0%   | 1.2    | 513.9  |

**2. Recent Stock Price Movements:**

*   **Current Price:** 120.53
*   **Previous Close:** 119.11
*   **Change:** 1.19
*   **5-day SMA:** 118.52
*   **20-day SMA:** 117.54
*   **60-day SMA:** 115.83

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment)
*   **RSI:** 58.15
*   **PPO:** 0.11
*   **Hybrid Signal:** Buy 90%
*   **Recent Relative Divergence Change (20 days):** -2.3 (Short-term decline)
*   **Expected Return (%):** -152.2%

**4. Recent News:**

*   XOM hits 52-week high.
*   XOM raises its 2030 corporate plan outlook.
*   Positive news related to Guyana's oil output and Exxon's investments there.

**5. Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 2.22 (Buy)
*   **Target Price (avg/high/low):** 131.56 / 158.00 / 109.00

**Analysis:**

*   **Underperformance:** XOM has significantly underperformed the S&P 500 (VOO) over the period examined, with a large negative divergence. However, the relative divergence of 15.9% suggests that the recent underperformance is not as extreme compared to its historical fluctuations versus the S&P 500.
*   **Mixed Financial Ratios:** The Alpha, Beta and Financial Ratios table reveals a mixed history. Notice the large negative Alpha values in recent years, indicating XOM has not performed as well as expected given the risk (Beta).
*   **Price Trend:** The current price is above the 5-day, 20-day, and 60-day SMAs, indicating a potential short-term upward trend. However, the recent relative divergence change suggests a short-term decline previously.
*   **Technicals:** The RSI is around 58, indicating neutral momentum. The PPO is relatively low, suggesting the price is close to its moving average. The MRI of 0.9 suggests a medium investment recommendation, while the hybrid signal leans towards buying.
*   **Concerning Expected Return:** The **negative** expected return of -152.2% is a very serious red flag. This number indicates that the model predicts significant underperformance compared to the S&P 500 if an investment is made at this point and held for the long term. *This is the most concerning data point.*
*   **Positive News:** The recent news is mostly positive (hitting a 52-week high, increased outlook, Guyana oil output). This might be a temporary boost that could be contributing to the recent price increase, or that the market is viewing XOM more favorably lately.
*   **Analyst Optimism:** Despite the underperformance, analysts maintain a "Buy" consensus and a target price higher than the current price, suggesting they anticipate future growth.

**Comprehensive Summary:**

While Exxon Mobil's stock price has shown recent upward momentum and positive news flow, the underperformance compared to the S&P 500, coupled with the highly negative expected return, raises serious concerns. The analyst consensus provides a more optimistic outlook, but these should be weighed against the poor historical and modeled future performance. It's vital to examine the assumptions and methodologies behind that expected return calculation, and to understand the rationale for the disconnect between it, analyst consensus, and recent price action. A buy recommendation may not be appropriate for risk-averse investors.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.